Clinical
RSSArticles
-
Warning: Reactivation of Hepatitis B Virus Coinfection During Treatment of Chronic Hepatitis C Virus Infection
Prior to initiation of hepatitis C virus treatment with direct-acting antivirals, patients should be screened for hepatitis B virus coinfection.
-
Changing Gut Microbiota to Prevent Type 2 Diabetes
The long-term consumption of a healthy diet, such as the Mediterranean diet or low-fat/high complex carbohydrate diets, may exert a protective effect on the development of type 2 diabetes by changing the gut microbiota.
-
Statins Associated with Lower Parkinson’s Risk in Diabetics
In approximately 50,000 individuals with Parkinson’s disease and diabetes, identified from a National Health Insurance database in Taiwan, statin use was dose-dependently associated with lower risk of Parkinson’s disease.
-
Alzheimer’s Disease: What the Primary Care Physician Needs to Know
This article explores current medical approaches to Alzheimer’s dementia, the most common subtype of the known dementias or neurocognitive disorders. Preventive treatment is at the forefront of efforts to defeat this progressively impairing disorder; but to be effective, intervention must start well before symptoms begin. The role of the primary care provider in initiating vigorous and early preventive measures and applying appropriate pharmacologic and non-pharmacologic interventions at each stage of disease progression is reviewed and discussed.
-
Should We Still Be Performing Annual Pelvic Exams?
<>The recent draft guidance from the United States Preventive Services Task Force (USPSTF) on the utility of periodic screening with the pelvic examination has inspired renewed debate on this topic. -
Glucose Screening: The Meaning of a Single Abnormal Value in a 3-hour Glucose Tolerance Test
A recent 25-study meta-analysis has shown that patients having only one elevation in a three-hour glucose tolerance test have similar maternal and fetal outcomes as patients diagnosed to have bona fide gestational diabetes.
-
HPV Testing: An Approach Whose Time Has Come?
A recent study found that genotyping for human papillomavirus 16/18 is a reasonable approach to help calculate the risk of progression to CIN3 or worse.
-
Hormonal Contraception: A Risk Factor for Depression?
A population-based study suggests that hormonal contraception increases the risk of treatment for depression, but bias provides a more likely explanation for the association.
-
What Every Prescriber Should Know: FDA’s Updated Warnings for Fluoroquinolone Antibiotics
Fluoroquinolones have risks and benefits that should be carefully considered before prescribing to patients for uncomplicated bacterial infections.
-
FDA Actions
In this section: The FDA adds warning label to testosterone products, approves new treatment for non-small cell lung cancer, greenlights drug for soft tissue sarcoma patients, and gives its blessing to the so-called 'artificial pancreas.'